Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EV/Core EBITDA

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 25.2344.7216.898.4210.56

What is the latest EV/Core EBITDA ratio of NEULAND LABORATORIES ?

The latest EV/Core EBITDA ratio of NEULAND LABORATORIES is 25.23 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202625.23
Mar202544.72
Mar202416.89
Mar20238.42
Mar202210.56

How is EV/Core EBITDA of NEULAND LABORATORIES Trending?

Years EV/Core EBITDA % Change
Mar2026 25.23
-43.58
Mar2025 44.72
164.77
Mar2024 16.89
100.59
Mar2023 8.42
-20.27
Mar2022 10.56 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EV/Core EBITDA ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹24,877.1 Cr -2.9% -9.6% 24.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,150.0 Cr 0.8% -2.1% 4.8% Stock Analytics
DIVIS LABORATORIES ₹266,265.0 Cr 4.9% 7.9% 54.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr 1.6% -2.7% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹114,351.0 Cr 2.6% 14.2% 3.9% Stock Analytics
CIPLA ₹112,474.0 Cr 2.4% 3.4% -12% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-2.9%

-9.6%

24.4%

SENSEX

4.5%

6.1%

-9.3%


You may also like the below Video Courses